Selected research
Industry Growth & Trends
Global Male Infertility Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Male Infertility market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Male Infertility is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Male Infertility is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Male Infertility is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Male Infertility market include CCRM, Male Infertility, Monash IVF, The Cooper, Ferring Pharmaceuticals, Merck & Co and Thermo Fisher, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Male Infertility market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Male Infertility market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Male Infertility market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Male Infertility.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Male Infertility market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Male Infertility Market by Company
CCRM
Male Infertility
Monash IVF
The Cooper
Ferring Pharmaceuticals
Merck & Co
Thermo Fisher
Male Infertility Segment by Type
ART
Fertility Drugs
Fertility Surgery
Artificial Insemination
Others
Male Infertility Segment by Application
Fertility Clinics
Research Banks
Hospitals
Male Infertility Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Male Infertility market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Male Infertility and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Male Infertility.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Male Infertility companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ART
- Fertility Drugs
- Fertility Surgery
- Artificial Insemination
- Others
Applications
- Fertility Clinics
- Research Banks
- Hospitals
Companies covered
- CCRM
- Male Infertility
- Monash IVF
- The Cooper
- Ferring Pharmaceuticals
- Merck & Co
- Thermo Fisher
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Male Infertility Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Male Infertility Market Size by Region (2021-2032)
- 1.4.1 Global Male Infertility Market Size by Region (2021-2026)
- 1.4.2 Global Male Infertility Market Size by Region (2027-2032)
- 1.5 Key Regions Male Infertility Market Size (2021-2032)
- 1.5.1 North America Male Infertility Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Male Infertility Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Male Infertility Market Size Growth Rate (2021-2032)
- 1.5.4 South America Male Infertility Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Male Infertility Market Size Growth Rate (2021-2032)
2 Male Infertility Market by Type
- 2.1 Type Introduction
- 2.1.1 ART
- 2.1.2 Fertility Drugs
- 2.1.3 Fertility Surgery
- 2.1.4 Artificial Insemination
- 2.1.5 Others
- 2.2 Global Male Infertility Market Size by Type
- 2.2.1 Global Male Infertility Market Size Overview by Type (2021-2032)
- 2.2.2 Global Male Infertility Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Male Infertility Market Size Forecasted by Type (2027-2032)
- 2.3 Global Male Infertility Market Size by Regions
- 2.3.1 North America Male Infertility Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Male Infertility Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Male Infertility Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Male Infertility Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Male Infertility Market Size Breakdown by Type (2021-2026)
3 Male Infertility Market by Application
- 3.1 Type Introduction
- 3.1.1 Fertility Clinics
- 3.1.2 Research Banks
- 3.1.3 Hospitals
- 3.2 Global Male Infertility Market Size by Application
- 3.2.1 Global Male Infertility Market Size Overview by Application (2021-2032)
- 3.2.2 Global Male Infertility Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Male Infertility Market Size Forecasted by Application (2027-2032)
- 3.3 Global Male Infertility Market Size by Regions
- 3.3.1 North America Male Infertility Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Male Infertility Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Male Infertility Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Male Infertility Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Male Infertility Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Male Infertility Industry Trends
- 4.2 Male Infertility Industry Drivers
- 4.3 Male Infertility Industry Opportunities and Challenges
- 4.4 Male Infertility Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Male Infertility Revenue (2021-2026)
- 5.2 Global Male Infertility Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Male Infertility Key Company Headquarters & Area Served
- 5.4 Global Male Infertility Company, Product Type & Application
- 5.5 Global Male Infertility Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Male Infertility Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Male Infertility Players Market Share by Revenue in 2025
- 5.6.3 2025 Male Infertility Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 CCRM
- 6.1.1 CCRM Company Information
- 6.1.2 CCRM Business Overview
- 6.1.3 CCRM Male Infertility Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 CCRM Male Infertility Product Portfolio
- 6.1.5 CCRM Recent Developments
- 6.2 Male Infertility
- 6.2.1 Male Infertility Company Information
- 6.2.2 Male Infertility Business Overview
- 6.2.3 Male Infertility Male Infertility Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Male Infertility Male Infertility Product Portfolio
- 6.2.5 Male Infertility Recent Developments
- 6.3 Monash IVF
- 6.3.1 Monash IVF Company Information
- 6.3.2 Monash IVF Business Overview
- 6.3.3 Monash IVF Male Infertility Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Monash IVF Male Infertility Product Portfolio
- 6.3.5 Monash IVF Recent Developments
- 6.4 The Cooper
- 6.4.1 The Cooper Company Information
- 6.4.2 The Cooper Business Overview
- 6.4.3 The Cooper Male Infertility Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 The Cooper Male Infertility Product Portfolio
- 6.4.5 The Cooper Recent Developments
- 6.5 Ferring Pharmaceuticals
- 6.5.1 Ferring Pharmaceuticals Company Information
- 6.5.2 Ferring Pharmaceuticals Business Overview
- 6.5.3 Ferring Pharmaceuticals Male Infertility Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Ferring Pharmaceuticals Male Infertility Product Portfolio
- 6.5.5 Ferring Pharmaceuticals Recent Developments
- 6.6 Merck & Co
- 6.6.1 Merck & Co Company Information
- 6.6.2 Merck & Co Business Overview
- 6.6.3 Merck & Co Male Infertility Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Merck & Co Male Infertility Product Portfolio
- 6.6.5 Merck & Co Recent Developments
- 6.7 Thermo Fisher
- 6.7.1 Thermo Fisher Company Information
- 6.7.2 Thermo Fisher Business Overview
- 6.7.3 Thermo Fisher Male Infertility Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Thermo Fisher Male Infertility Product Portfolio
- 6.7.5 Thermo Fisher Recent Developments
7 North America
- 7.1 North America Male Infertility Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Male Infertility Market Size by Country (2021-2026)
- 7.3 North America Male Infertility Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Male Infertility Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Male Infertility Market Size by Country (2021-2026)
- 8.3 Europe Male Infertility Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Male Infertility Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Male Infertility Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Male Infertility Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Male Infertility Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Male Infertility Market Size by Country (2021-2026)
- 10.3 South America Male Infertility Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Male Infertility Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Male Infertility Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Male Infertility Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst